Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma
Figure 4
Rosuvastatin prevents arterialisation in HCC livers. (a) Representative images of SMA immunostaining in arteries in normal livers (N, ), in untreated HCC and in rosuvastatin-treated HCC livers (/group) at 16 weeks. SMA stained smooth muscle cells lining arteries (white arrow). (b) Quantification of SMA-positive arteries per section in untreated HCC, and in rosuvastatin-treated livers (: group). Data are mean ± SEM, .
